Performance of 2-Deoxy-2-[F-18]fluoro-d-glucose Positron Emission Tomography and Integrated PET/CT in Restaged Breast Cancer Patients
✍ Scribed by Barbara J. Fueger; Wolfgang A. Weber; Andrew Quon; Tyler L. Crawford; M. S. Allen-Auerbach; B. S. Halpern; Osman Ratib; Michael E. Phelps; Johannes Czernin
- Publisher
- Springer-Verlag
- Year
- 2005
- Tongue
- English
- Weight
- 363 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1536-1632
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
^18^F‐fluoro‐2‐deoxy‐D‐glucose–positron emission tomography (FDG‐PET)/PET‐computed tomography diagnostic studies may play a potential role in the staging and restaging of patients with cervical cancer. Recent work has demonstrated another important aspect of FDG‐PET in predicting the prognosis for p
## Abstract ## BACKGROUND The clinical value of positron emission tomography (PET) with [^18^F]fluoro‐2‐deoxy‐D‐glucose (FDG) for primary staging in cervical carcinoma appears to be promising. The authors sought to evaluate the diagnostic efficacy and benefit of PET in restaging cervical carcinoma